DK0403333T3 - Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf - Google Patents

Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf

Info

Publication number
DK0403333T3
DK0403333T3 DK90401520T DK90401520T DK0403333T3 DK 0403333 T3 DK0403333 T3 DK 0403333T3 DK 90401520 T DK90401520 T DK 90401520T DK 90401520 T DK90401520 T DK 90401520T DK 0403333 T3 DK0403333 T3 DK 0403333T3
Authority
DK
Denmark
Prior art keywords
hiv
gene
nucleic acid
siv
sequence
Prior art date
Application number
DK90401520T
Other languages
English (en)
Inventor
Luc Montagnier
Maurice Moncany
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8907354A external-priority patent/FR2647809B1/fr
Priority claimed from FR8912371A external-priority patent/FR2652091B1/fr
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0403333T3 publication Critical patent/DK0403333T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/974Aids related test
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90401520T 1989-06-02 1990-06-05 Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf DK0403333T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8907354A FR2647809B1 (fr) 1989-06-02 1989-06-02 Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR8912371A FR2652091B1 (fr) 1989-09-20 1989-09-20 Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus.

Publications (1)

Publication Number Publication Date
DK0403333T3 true DK0403333T3 (da) 2000-03-20

Family

ID=26227366

Family Applications (5)

Application Number Title Priority Date Filing Date
DK06013029T DK1715064T3 (da) 1989-06-02 1990-06-05 Nucleotidsekvenser fra HIV-1-, HIV-2- og SIV-retrovirusgenomer samt deres anvendelse til mangfoldiggörelse af pol-sekvenser fra disse retrovira og til diagnosticering in vitro af infektioner fremkaldt af disse vira
DK90401520T DK0403333T3 (da) 1989-06-02 1990-06-05 Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf
DK97110543T DK0806484T3 (da) 1989-06-02 1990-06-05 Syntese af proteiner eller polypeptider kodet af en nucleotidsekvens af HIV-1, HIV-2 eller SIV.
DK05014676T DK1642987T3 (da) 1989-06-02 1990-06-05 Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser
DK07025195.4T DK2011888T3 (da) 1989-06-02 1990-06-05 Nukleotidsekvenser resulterende fra genomet af HIV-1-, og SIV-retroviraene og deres anvendelser til især apmplifikation af genomerne af disse retrovira og til in vitro-diagnose af infektioner forårsaget af disse vira

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06013029T DK1715064T3 (da) 1989-06-02 1990-06-05 Nucleotidsekvenser fra HIV-1-, HIV-2- og SIV-retrovirusgenomer samt deres anvendelse til mangfoldiggörelse af pol-sekvenser fra disse retrovira og til diagnosticering in vitro af infektioner fremkaldt af disse vira

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK97110543T DK0806484T3 (da) 1989-06-02 1990-06-05 Syntese af proteiner eller polypeptider kodet af en nucleotidsekvens af HIV-1, HIV-2 eller SIV.
DK05014676T DK1642987T3 (da) 1989-06-02 1990-06-05 Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser
DK07025195.4T DK2011888T3 (da) 1989-06-02 1990-06-05 Nukleotidsekvenser resulterende fra genomet af HIV-1-, og SIV-retroviraene og deres anvendelser til især apmplifikation af genomerne af disse retrovira og til in vitro-diagnose af infektioner forårsaget af disse vira

Country Status (12)

Country Link
US (6) US5688637A (da)
EP (5) EP1642987B1 (da)
JP (2) JP3428012B2 (da)
AT (5) ATE404699T1 (da)
CA (3) CA2685262A1 (da)
DE (7) DE07025195T1 (da)
DK (5) DK1715064T3 (da)
ES (5) ES2321326T3 (da)
GR (1) GR3032261T3 (da)
HK (3) HK1097574A1 (da)
SG (1) SG47868A1 (da)
WO (1) WO1990015066A2 (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022814B1 (en) 1992-01-21 2006-04-04 Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
DE07025195T1 (de) * 1989-06-02 2009-05-07 Institut Pasteur Nukleotidsequenzen des Genoms von Retroviren des Typs HIV-1, HIV-2 und SIV und deren Anwendungen, insbesondere zur Amplifikation von Genomen dieser Retroviren und für die In-Vitro-Diagnostik von durch diese Viren ausgelösten Infektionen
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
JPH04152899A (ja) * 1990-10-17 1992-05-26 Shionogi & Co Ltd 2段階pcr法によるhiv―1ゲノムの検出法およびオリゴヌクレオチド
FR2677039B1 (fr) * 1991-05-31 1994-09-09 Cis Bio Int Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
PT726962E (pt) 1991-12-23 2006-10-31 Chiron Corp Sondas para hiv para uso em ensaios de hibridacao em sanduiche em fase de solucao
FR2692279B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
JP4108118B2 (ja) 1993-03-26 2008-06-25 ジェン−プローブ・インコーポレイテッド ヒト・免疫不全ウイルス1型の検出
AU7568794A (en) * 1993-08-20 1995-03-21 St. Luke's-Roosevelt Hospital Center Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof
US5733781A (en) * 1994-07-19 1998-03-31 Gen-Probe Incorporated Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
EP0877940A1 (en) 1995-12-05 1998-11-18 Donald R. Branch Methods for the early detection of hiv infection
US6265152B1 (en) * 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
DE19644248A1 (de) * 1996-10-24 1998-04-30 Boehringer Mannheim Gmbh Primer und Probes zum Nachweis von HIV
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
US5962665A (en) * 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
CA2302201A1 (en) * 1997-09-26 1999-04-08 Visible Genetics Inc. Method and kit for evaluation of hiv mutations
US6228128B1 (en) 1997-11-10 2001-05-08 Charlotte Johansen Antimicrobial activity of laccases
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
US6303293B1 (en) * 1999-02-02 2001-10-16 Ortho-Clinical Diagnostics, Inc. Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
WO2000046403A2 (en) * 1999-02-03 2000-08-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES Methods and reagents for molecular detection of hiv-1 groups m, n and o
DE19908766C2 (de) * 1999-02-19 2001-02-15 Ulrich Schubert Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien
WO2000068436A1 (en) * 1999-05-07 2000-11-16 Nationales Zentrum Für Retroviren Detection system for human immunodeficiency virus based on nucleic acid amplification
FR2798385B1 (fr) * 1999-06-21 2003-09-05 Bio Merieux Procede de recherche d'une resistance aux anti-proteases chez des souches du virus vih-2
ATE456677T1 (de) 1999-07-09 2010-02-15 Gen Probe Inc Hiv-1 detektion mittels nukleinsäureamplifizierung
US20030228600A1 (en) * 2000-07-14 2003-12-11 Eppendorf 5 Prime, Inc. DNA isolation method and kit
CA2731495C (en) 2000-09-01 2015-02-03 Gen-Probe Incorporated Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
AU2002230545B2 (en) 2000-10-23 2006-09-21 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (HIV-2)
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
US7847087B2 (en) * 2001-03-05 2010-12-07 Siemens Healthcare Diagnostics Inc. Methods and primers for evaluating HIV-1 mutations
JP4701532B2 (ja) * 2001-04-26 2011-06-15 東ソー株式会社 Hiv−1rnaの増幅および検出法
US6852491B2 (en) * 2001-09-04 2005-02-08 Abbott Laboratories Amplification and detection reagents for HIV-1
CA2470763A1 (en) * 2001-12-18 2003-06-26 Mondobiotech Laboratories Anstalt Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
US20030215793A1 (en) * 2002-01-17 2003-11-20 Hahn Beatrice H. Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
CN1301263C (zh) 2002-12-18 2007-02-21 北京昭衍新药研究中心 一组抗hiv感染及防治艾滋病的核苷酸序列及其应用
US20050222068A1 (en) 2003-10-23 2005-10-06 Mourich Dan V Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
US7255996B2 (en) 2003-12-19 2007-08-14 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
TW200613554A (en) 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
US7993647B2 (en) 2004-07-01 2011-08-09 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies to HIV-1 and methods of using same
CN101374550B (zh) 2004-09-14 2013-05-15 阿戈斯治疗公司 病原体的非毒株依赖性扩增和针对其的疫苗
US20090050492A1 (en) * 2005-08-02 2009-02-26 Board Of Trustees Of Michigan State University Nanoporous silicon-based electrochemical nucleic acid biosensor
WO2008115427A2 (en) * 2007-03-16 2008-09-25 454 Life Sciences Corporation System and method for detection of hiv drug resistant variants
WO2009017743A2 (en) 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
CA2746508A1 (en) 2008-12-17 2010-07-15 Avi Biopharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2691530B1 (en) 2011-06-10 2018-03-07 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN102964898B (zh) 2011-08-05 2016-05-25 罗门哈斯公司 具有改进的亲水污渍排斥性的水性涂料组合物
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000189B1 (ko) 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
US5386022A (en) 1985-03-28 1995-01-31 Hoffman-La Roche Inc. Primes and probes for the amplification and detection of aids associated nucleic acids
US5008182A (en) 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DK171161B1 (da) 1985-03-28 1996-07-08 Hoffmann La Roche Fremgangsmåde til påvisning af forekomst eller fravær af mindst én specifik nukleinsyresekvens i en prøve eller til skelnen mellem to forskellige nukleinsyresekvenser i denne prøve
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
US5176995A (en) 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
US5008185A (en) 1985-11-04 1991-04-16 Cell Analysis Systems, Inc. Methods and apparatus for the quantitation of nuclear proteins
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
NZ219024A (en) 1986-01-22 1990-04-26 Pasteur Institut Hiv-2 retrovirus protein and nucleic acid sequences and detection methods
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
US5824482A (en) * 1986-06-23 1998-10-20 Institut Pasteur Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
DE3785658T2 (de) * 1986-08-11 1993-08-12 Siska Diagnostics Inc Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden.
EP0269520A3 (fr) * 1986-11-21 1988-08-24 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
US5268268A (en) 1986-11-26 1993-12-07 Hoffmann-La Roche Inc. Detection of HTLVI and HTLVII viruses by hybridization
US5079351A (en) * 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
EP0272098A3 (en) * 1986-12-15 1990-06-06 City Of Hope National Medical Center Method for amplification and detection of rna sequences
WO1988005440A1 (fr) * 1987-01-16 1988-07-28 Institut Pasteur Peptides ayant des proprietes immunologiques 2-hiv-2
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
US4963532A (en) 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
US5389512A (en) 1988-10-07 1995-02-14 Hoffman-La Roche Inc. Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
FR2647856B1 (fr) * 1989-05-31 1994-03-04 Framatome Dispositif auxiliaire de relachement commande a distance pour un mecanisme a action positive
DE07025195T1 (de) * 1989-06-02 2009-05-07 Institut Pasteur Nukleotidsequenzen des Genoms von Retroviren des Typs HIV-1, HIV-2 und SIV und deren Anwendungen, insbesondere zur Amplifikation von Genomen dieser Retroviren und für die In-Vitro-Diagnostik von durch diese Viren ausgelösten Infektionen

Also Published As

Publication number Publication date
US5786177A (en) 1998-07-28
HK1097574A1 (en) 2007-06-29
DK1715064T3 (da) 2009-06-22
EP0806484A2 (fr) 1997-11-12
DK0806484T3 (da) 2006-08-14
US7777020B2 (en) 2010-08-17
DE69034260D1 (de) 2008-09-25
ATE404699T1 (de) 2008-08-15
SG47868A1 (en) 1998-04-17
DE69034220D1 (de) 2006-05-24
US5688637A (en) 1997-11-18
ATE423856T1 (de) 2009-03-15
DE69034220T2 (de) 2006-12-28
ES2275451T1 (es) 2007-06-16
EP0403333A2 (fr) 1990-12-19
EP1715064A8 (fr) 2007-05-16
ES2321326T3 (es) 2009-06-04
ATE185379T1 (de) 1999-10-15
DK1642987T3 (da) 2008-12-01
EP1642987A2 (fr) 2006-04-05
DE05014676T1 (de) 2007-05-10
EP0403333A3 (fr) 1991-11-21
ES2315215T1 (es) 2009-04-01
DE69034267D1 (de) 2010-06-10
DE69033311T2 (de) 2000-02-17
ES2275451T3 (es) 2009-02-16
US20050037340A1 (en) 2005-02-17
ATE466111T1 (de) 2010-05-15
US20060035260A1 (en) 2006-02-16
EP2011888A1 (fr) 2009-01-07
DE69033311D1 (de) 1999-11-11
US6194142B1 (en) 2001-02-27
EP1642987B1 (fr) 2008-08-13
EP1715064B1 (fr) 2009-02-25
EP0806484A3 (fr) 2000-09-13
JP2000093187A (ja) 2000-04-04
CA2585164C (fr) 2010-02-02
ATE323183T1 (de) 2006-04-15
EP1642987A3 (fr) 2006-08-23
EP0403333B1 (fr) 1999-10-06
JPH04507043A (ja) 1992-12-10
CA2585164A1 (fr) 1990-12-13
EP0806484B1 (fr) 2006-04-12
CA2685262A1 (fr) 1990-12-13
HK1092839A1 (en) 2007-02-16
DE69034265D1 (de) 2009-04-09
JP3428012B2 (ja) 2003-07-22
CA2062829A1 (fr) 1990-12-03
CA2062829C (fr) 2007-08-07
ES2262166T3 (es) 2006-11-16
EP1715064A1 (fr) 2006-10-25
WO1990015066A3 (fr) 1991-04-18
HK1125136A1 (en) 2009-07-31
WO1990015066A2 (fr) 1990-12-13
US7759477B2 (en) 2010-07-20
DE07025195T1 (de) 2009-05-07
ES2139567T3 (es) 2000-02-16
GR3032261T3 (en) 2000-04-27
DK2011888T3 (da) 2010-08-09
EP2011888B1 (fr) 2010-04-28
US7078516B1 (en) 2006-07-18

Similar Documents

Publication Publication Date Title
DK0403333T3 (da) Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf
Kwoh et al. Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format.
KR0148265B1 (ko) 자가-지속 서열 복제 시스템
US5389512A (en) Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
JP3802110B2 (ja) 核酸の同時増幅方法並びにそのための組成物、試験キット及び試験装置
KR100901084B1 (ko) Hiv-1 및 hiv-2를 효율적으로 검출하기 위한 올리고뉴클레오타이드 역전사 프라이머, 이의 사용 방법 및 이를 포함하는 키트
DE50113454D1 (de) Verfahren zur bestimmung des methylierungsgrades von bestimmten cytosinen in genomischer dna im sequenzkontext 5'-cpg-3'
KR870007427A (ko) 증폭 및 하이브리드화로 바이러스를 검출하는 방법
JPH08242898A (ja) 免疫不全ウイルス−1型増幅用プライマー
RU98100921A (ru) Праймеры для обнаружения вич-1
Thomas et al. Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis
JP2004500014A (ja) Hivを検出するための新規のプライマーおよびプローブ
JP2020146066A5 (da)
RU2010154139A (ru) Способ обнаружения респираторных вирусных агентов в образце
JP6164590B2 (ja) ウシ白血病ウイルス検出用プライマーセット、及びその利用
CN114369649A (zh) 一种特异的选择扩增及多重pcr方法和应用
JP2007135469A (ja) 核酸増幅方法
WO2021033648A1 (ja) ヌクレオチド配列の増幅方法及び配列決定方法
WO2000014272A1 (en) Measurement of persistent-latent hiv viral load
EP0756639B1 (en) Methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus and primers to be used in the methods
WO2007120675A2 (en) Method of detecting genetic mutations
González-Villaseñor et al. A solid phase plate assay for HIV-1 genotyping
DK200401109A (da) Kit til multiplicering og påvisning af nukleinsyresekvenser